Andrew Awad
Overview
Explore the profile of Andrew Awad including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
70
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tran V, Awad A, Scardamaglia L, Ross G
Australas J Dermatol
. 2025 Feb;
PMID: 39985229
No abstract available.
2.
Arasu A, Awad A, Tran V, Ross G
Australas J Dermatol
. 2024 Dec;
66(1):e24-e27.
PMID: 39686603
Treatment and management outcomes or patients with atopic dermatitis has significantly improved with the inclusion of dupilumab into the pharmaceutical benefits scheme, as a safe and effective treatment. Ocular surface...
3.
James F, Goh M, Vogrin S, Ng I, Douglas A, Holmes N, et al.
World Allergy Organ J
. 2024 Aug;
17(8):100936.
PMID: 39211425
Background: Severe cutaneous adverse reactions (SCAR) are a group of delayed presumed T-cell mediated hypersensitivities associated with significant morbidity and mortality. Despite their shared global healthcare burden and impact, the...
4.
Awad A, Nirenberg A, Colla T, Sinclair R
Clin Exp Dermatol
. 2024 May;
49(12):1733-1734.
PMID: 38747355
No abstract available.
5.
Awad A, Sharma P, Bhoyrul B
Clin Exp Dermatol
. 2024 Feb;
49(8):898-899.
PMID: 38372460
No abstract available.
6.
Awad A, Mouhtouris E, Nguyen-Robertson C, Holmes N, Chua K, Copaescu A, et al.
J Allergy Clin Immunol Glob
. 2023 Oct;
1(1):16-21.
PMID: 37780076
Background: Drug-induced severe cutaneous adverse reactions (SCARs) are presumed T-cell-mediated hypersensitivities associated with significant morbidity and mortality. Traditional testing methods, such as patch or intradermal testing, are limited by a...
7.
Awad A, Mouhtouris E, Clatch A, James F, Chua K, Holmes N, et al.
J Allergy Clin Immunol Pract
. 2023 Oct;
12(1):232-235.e2.
PMID: 37778629
No abstract available.
8.
Copaescu A, Vogrin S, James F, Chua K, Rose M, De Luca J, et al.
JAMA Intern Med
. 2023 Jul;
183(9):944-952.
PMID: 37459086
Importance: Fewer than 5% of patients labeled with a penicillin allergy are truly allergic. The standard of care to remove the penicillin allergy label in adults is specialized testing involving...
9.
Awad A, Nirenberg A, Sinclair R
F1000Res
. 2023 Jun;
11:945.
PMID: 37360939
Porphyria cutanea tarda (PCT) is a complex metabolic disease resulting from altered activity of the enzyme uroporphyrinogen decarboxylase (UROD) in the liver resulting in accumulation of uroporphyrin. PCT presents as...
10.
De Luca J, Awad A, Vogrin S, Waldron J, McInnes K, Gibney G, et al.
J Allergy Clin Immunol Pract
. 2023 May;
11(8):2605-2607.e2.
PMID: 37178767
No abstract available.